Effect of a personalized mobile application on glucose control in adults with prediabetes and type 2 diabetes: an exploratory pilot randomized controlled trial (Preprint)
Authors:
- Elena LalamaELElena Lalama
- Marta CsanalosiMCMarta Csanalosi
- Stefan KabischSKStefan Kabisch
- Saskia Wilson-BarnesSWSaskia Wilson-Barnes
- Lazaros P. GymnopoulosLazaros P. Gymnopoulos
- Kosmas DimitropoulosKosmas Dimitropoulos
- Konstantinos RouskasKRKonstantinos Rouskas
- Argiriou AnagnostisArgiriou Anagnostis
- Ioannis OikonomidisIOIoannis Oikonomidis
- Leontios HadjileontiadisLHLeontios Hadjileontiadis
- Veronique CornelissenVeronique Cornelissen
- Maria HassapidouMHMaria Hassapidou
Open Access
- 14 November 2025
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13, e87692
Abstract
The incidence of type 2 diabetes (T2D) continues to increase, and the lack of individualized therapy strategies hinders patient engagement with and commitment to a healthy lifestyle. The PROTEIN project aimed to facilitate users in choosing healthy living, thereby improving their metabolism and T2D management. This study aims to assess the efficacy of a personalized mobile app to achieve a 5% time in range (TIR) improvement over a 12-week intervention in adults with prediabetes or T2D. We conducted an exploratory pilot randomized controlled trial with 21 individuals with T2D or prediabetes who used a continuous glucose monitoring system and the PROTEIN mobile app for personalized meals and exercise recommendations based on their glucose levels and physical activity. The TIR of the participants increased (P<.05; from 71.8%, SD 27.3% to 76%, SD 28.1%) with individual use of the PROTEIN app but did not achieve a 5% improvement overall; however, given the exploratory design and small sample size, this finding should be interpreted with caution. Glycated hemoglobin, fasting blood glucose, and body weight did not fluctuate throughout the 12-week intervention. The dropout rate was high, and the average duration of use of the PROTEIN app was 42 (range 5-84) days. Our results showed a modest increase in TIR with the use of the PROTEIN app; however, considering the exploratory design and small sample size, this finding should be interpreted as preliminary. Integrating wearables and automated personalization for well-being is an innovative approach that must keep pace with the accelerated development of ever-evolving technologies. The COVID-19 pandemic was a major obstacle to recruitment in our clinical trial. ClinicalTrials.gov NCT05951140; https://clinicaltrials.gov/study/NCT05951140.Keywords
This publication has 34 references indexed in Scilit:
- Mobile apps for diabetes self-management: An updated review of app features and effectivenessJournal of Behavioral Medicine, 2024
- A pilot trial guiding development and investigating feasibility and usability as well as preliminary effectiveness of the PROTEIN application: personalized nutrition for healthy livingEuropean Journal of Preventive Cardiology, 2023
- Evidence-based European recommendations for the dietary management of diabetesDiabetologia, 2023
- Can a mobile application deliver appropriate, acceptable and usable personalised nutrition advice to UK adultsProceedings of the Nutrition Society, 2023
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 daysInternational Journal of Diabetes in Developing Countries, 2022
- Health app policy: international comparison of nine countries’ approachesnpj Digital Medicine, 2022
- Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 DiabetesDiabetes Therapy, 2021
- Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working GroupDiabetologia, 2019
- Motivation for diet and exercise management among adults with type 2 diabetesScandinavian Journal of Caring Sciences, 2011